Related Experiment Video
Updated: Feb 27, 2026

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
Published on: April 7, 2015
Dissecting Kawasaki disease: a state-of-the-art review
S M Dietz1, D van Stijn2, D Burgner3,4,5
1Department of Pediatric Hematology, Immunology and Infectious Diseases, Emma Childrens Hospital, Academic Medical Centre (AMC), Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands. s.m.dietz@amc.nl.
Insights
Kawasaki disease (KD) is a pediatric vasculitis causing coronary artery aneurysms (CAA). While IVIG is standard treatment, 10-20% of patients require further therapy, and long-term cardiovascular risk requires ongoing study.
Area of Science:
- Pediatric rheumatology
- Immunology
- Cardiology
Background:
- Kawasaki disease (KD) is a leading cause of acquired pediatric heart disease.
- It presents with persistent fever and systemic inflammation, primarily affecting coronary arteries.
- Coronary artery aneurysms (CAA) are the main complication, potentially leading to myocardial infarction.
Purpose of the Study:
- To review the current understanding of KD etiology, diagnosis, and management.
- To highlight the challenges in treating non-responsive KD cases.
- To emphasize the importance of long-term cardiovascular risk assessment in KD survivors.
Main Methods:
- Review of existing literature on Kawasaki disease.
- Analysis of diagnostic criteria and imaging techniques (echocardiography).
- Discussion of treatment protocols, including intravenous immunoglobulin (IVIG) and alternative therapies.
Main Results:
- KD diagnosis relies on fever and specific clinical signs.
- Echocardiography is crucial for detecting and monitoring CAA using diameter and z-scores.
- 10-20% of patients exhibit resistance to standard IVIG treatment, necessitating further interventions.
Conclusions:
- Despite advances, KD etiology remains incompletely understood, with genetic factors like the ITPKC pathway gaining attention.
- Long-term follow-up is crucial as KD patients transition to adulthood.
- Understanding the long-term cardiovascular risks associated with KD and CAA is an evolving area of research.
Abstract:
Kawasaki disease (KD) is a pediatric vasculitis with coronary artery aneurysms (CAA) as its main complication. The diagnosis is based on the presence of persistent fever and clinical features including exanthema, lymphadenopathy, conjunctival injection, and changes to the mucosae and extremities. Although the etiology remains unknown, the current consensus is that it is likely caused by an (infectious) trigger initiating an abnormal immune response in genetically predisposed children. Treatment consists of high dose intravenous immunoglobulin (IVIG) and is directed at preventing the development of CAA. Unfortunately, 10-20% of all patients fail to respond to IVIG and these children need additional anti-inflammatory treatment. Coronary artery lesions are diagnosed by echocardiography in the acute and subacute phases. Both absolute arterial diameters and z-scores, adjusted for height and weight, are used as criteria for CAA. Close monitoring of CAA is important as ischemic symptoms or myocardial infarction due to thrombosis or stenosis can occur. These complications are most likely to arise in the largest, so-called giant CAA. Apart from the presence of CAA, it is unclear whether KD causes an increased cardiovascular risk due to the vasculitis itself.
Conclusion:
Many aspects of KD remain unknown, although there is growing knowledge on the etiology, treatment, and development and classification of CAA. Since children with previous KD are entering adulthood, long-term follow-up is increasingly important. What is known: • Kawasaki disease (KD) is a pediatric vasculitis with coronary artery damage as its main complication. • Although KD approaches its 50th birthday since its first description, many aspects of the disease remain poorly understood. What is new: • In recent years, multiple genetic candidate pathways involved in KD have been identified, with recently promising information about the ITPKC pathway. • As increasing numbers of KD patients are reaching adulthood, increasing information is available about the long-term consequences of coronary artery damage and broader cardiovascular risk.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies

